WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Day One Biopharmaceuticals revenue was $101.95M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $93.8M, up 1,044.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, DAWN annual revenue was $0.0, with N/A growth year-over-year.

DAWN revenue history

Current Revenue
$102.0M
Current Earnings
-$84.3M
Current Profit Margin
-82.7%

Be the first to know when DAWN announces revenue.

DAWN Revenue History By Year

DAWN Yearly RevenueDAWN RevenueDAWN ChangeDAWN Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Day One Biopharmaceuticals Revenue FAQ

What was DAWN's revenue last quarter?

Day One Biopharmaceuticals (NASDAQ: DAWN) reported Q3 2024 revenue of $93.76 million up Infinity% year over year. In the same quarter last year, Day One Biopharmaceuticals's revenue was $0.00.

What was Day One Biopharmaceuticals's revenue in 2023?

Day One Biopharmaceuticals's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Day One Biopharmaceuticals make in a day?

Based on Day One Biopharmaceuticals annual revenue for the past four years, DAWN makes an average of $0.00 per day.

What was Day One Biopharmaceuticals's annual revenue growth in the past year?

As of Q1 2025, Day One Biopharmaceuticals's revenue has grown null year over year. Day One Biopharmaceuticals's revenue in the past year totaled $101.95 million.

How much does Day One Biopharmaceuticals make in a year?

Day One Biopharmaceuticals's revenue by year for the past four years is:
  • Day One Biopharmaceuticals's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Day One Biopharmaceuticals's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Day One Biopharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Day One Biopharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.